Report Detail
Global Rabies Vaccine Market Growth 2019-2024
- RnM3002202 |
- 22 February, 2019 |
- Global |
- 135 Pages |
- LPI(LP Information) |
- Pharma & Healthcare
Rabies vaccine is an active immunizing agent used to prevent infection caused by the rabies virus. The vaccine works by causing your body to produce its own protection (antibodies) against the rabies virus.
Every year more than 5.5 million people have died for rabies, mostly in Asia and Africa. With the implementation of China's two-child policy, downstream demand for rabies vaccine will not decrease in the coming few years.
Rabies vaccine is an irreplaceable product, so profile of rabies vaccine is very large. But due to its security requirements than the general drugs, the entire vaccine industry from R & D, production to distribution, sales and after-sales feedback link subject to very strict regulation. So, production companies are not as much as we imagined.
The most wildly used rabies vaccine is Vero cell rabies vaccine (VRV), which takes about 80.85% in 2016.
Nowadays, global rabies vaccine production is mainly concentrated in China, Europe and North America. In 2016, China rabies vaccine production takes about 74.34% and Europe production takes about 7.46%.
According to this study, over the next five years the Rabies Vaccine market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2024, from US$ xx million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Rabies Vaccine business, shared in Chapter 3.
This report presents a comprehensive overview, market shares, and growth opportunities of Rabies Vaccine market by product type, application, key manufacturers and key regions and countries.
This study considers the Rabies Vaccine value and volume generated from the sales of the following segments:
Segmentation by product type: breakdown data from 2014 to 2019, in Section 2.3; and forecast to 2024 in section 11.7.
Vero Cell Rabies Vaccine
BHK
Chick Embryo Cell Rabies Vaccine
Other
Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 11.8.
Pre-exposure Prophylaxis
Post-exposure Prophylaxis
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
GSK (Novartis)
Sanofi-Pasteur
Chengda
Yisheng
Prcmise
VACN
Changsheng
BCHT
Hissen
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Rabies Vaccine consumption (value & volume) by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of Rabies Vaccine market by identifying its various subsegments.
Focuses on the key global Rabies Vaccine manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Rabies Vaccine with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Rabies Vaccine submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
Table of Contents
2019-2024 Global Rabies Vaccine Consumption Market Report
1 Scope of the Report
- 1.1 Market Introduction
- 1.2 Research Objectives
- 1.3 Years Considered
- 1.4 Market Research Methodology
- 1.5 Economic Indicators
- 1.6 Currency Considered
2 Executive Summary
- 2.1 World Market Overview
- 2.1.1 Global Rabies Vaccine Consumption 2014-2024
- 2.1.2 Rabies Vaccine Consumption CAGR by Region
- 2.2 Rabies Vaccine Segment by Type
- 2.2.1 Vero Cell Rabies Vaccine
- 2.2.2 BHK
- 2.2.3 Chick Embryo Cell Rabies Vaccine
- 2.2.4 Other
- 2.3 Rabies Vaccine Consumption by Type
- 2.3.1 Global Rabies Vaccine Consumption Market Share by Type (2014-2019)
- 2.3.2 Global Rabies Vaccine Revenue and Market Share by Type (2014-2019)
- 2.3.3 Global Rabies Vaccine Sale Price by Type (2014-2019)
- 2.4 Rabies Vaccine Segment by Application
- 2.4.1 Pre-exposure Prophylaxis
- 2.4.2 Post-exposure Prophylaxis
- 2.5 Rabies Vaccine Consumption by Application
- 2.5.1 Global Rabies Vaccine Consumption Market Share by Application (2014-2019)
- 2.5.2 Global Rabies Vaccine Value and Market Share by Application (2014-2019)
- 2.5.3 Global Rabies Vaccine Sale Price by Application (2014-2019)
3 Global Rabies Vaccine by Players
- 3.1 Global Rabies Vaccine Sales Market Share by Players
- 3.1.1 Global Rabies Vaccine Sales by Players (2017-2019)
- 3.1.2 Global Rabies Vaccine Sales Market Share by Players (2017-2019)
- 3.2 Global Rabies Vaccine Revenue Market Share by Players
- 3.2.1 Global Rabies Vaccine Revenue by Players (2017-2019)
- 3.2.2 Global Rabies Vaccine Revenue Market Share by Players (2017-2019)
- 3.3 Global Rabies Vaccine Sale Price by Players
- 3.4 Global Rabies Vaccine Manufacturing Base Distribution, Sales Area, Product Types by Players
- 3.4.1 Global Rabies Vaccine Manufacturing Base Distribution and Sales Area by Players
- 3.4.2 Players Rabies Vaccine Products Offered
- 3.5 Market Concentration Rate Analysis
- 3.5.1 Competition Landscape Analysis
- 3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
- 3.6 New Products and Potential Entrants
- 3.7 Mergers & Acquisitions, Expansion
4 Rabies Vaccine by Regions
- 4.1 Rabies Vaccine by Regions
- 4.1.1 Global Rabies Vaccine Consumption by Regions
- 4.1.2 Global Rabies Vaccine Value by Regions
- 4.2 Americas Rabies Vaccine Consumption Growth
- 4.3 APAC Rabies Vaccine Consumption Growth
- 4.4 Europe Rabies Vaccine Consumption Growth
- 4.5 Middle East & Africa Rabies Vaccine Consumption Growth
5 Americas
- 5.1 Americas Rabies Vaccine Consumption by Countries
- 5.1.1 Americas Rabies Vaccine Consumption by Countries (2014-2019)
- 5.1.2 Americas Rabies Vaccine Value by Countries (2014-2019)
- 5.2 Americas Rabies Vaccine Consumption by Type
- 5.3 Americas Rabies Vaccine Consumption by Application
- 5.4 United States
- 5.5 Canada
- 5.6 Mexico
- 5.7 Key Economic Indicators of Few Americas Countries
6 APAC
- 6.1 APAC Rabies Vaccine Consumption by Countries
- 6.1.1 APAC Rabies Vaccine Consumption by Countries (2014-2019)
- 6.1.2 APAC Rabies Vaccine Value by Countries (2014-2019)
- 6.2 APAC Rabies Vaccine Consumption by Type
- 6.3 APAC Rabies Vaccine Consumption by Application
- 6.4 China
- 6.5 Japan
- 6.6 Korea
- 6.7 Southeast Asia
- 6.8 India
- 6.9 Australia
- 6.10 Key Economic Indicators of Few APAC Countries
7 Europe
- 7.1 Europe Rabies Vaccine by Countries
- 7.1.1 Europe Rabies Vaccine Consumption by Countries (2014-2019)
- 7.1.2 Europe Rabies Vaccine Value by Countries (2014-2019)
- 7.2 Europe Rabies Vaccine Consumption by Type
- 7.3 Europe Rabies Vaccine Consumption by Application
- 7.4 Germany
- 7.5 France
- 7.6 UK
- 7.7 Italy
- 7.8 Russia
- 7.9 Spain
- 7.10 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
- 8.1 Middle East & Africa Rabies Vaccine by Countries
- 8.1.1 Middle East & Africa Rabies Vaccine Consumption by Countries (2014-2019)
- 8.1.2 Middle East & Africa Rabies Vaccine Value by Countries (2014-2019)
- 8.2 Middle East & Africa Rabies Vaccine Consumption by Type
- 8.3 Middle East & Africa Rabies Vaccine Consumption by Application
- 8.4 Egypt
- 8.5 South Africa
- 8.6 Israel
- 8.7 Turkey
- 8.8 GCC Countries
9 Market Drivers, Challenges and Trends
- 9.1 Market Drivers and Impact
- 9.1.1 Growing Demand from Key Regions
- 9.1.2 Growing Demand from Key Applications and Potential Industries
- 9.2 Market Challenges and Impact
- 9.3 Market Trends
10 Marketing, Distributors and Customer
- 10.1 Sales Channel
- 10.1.1 Direct Channels
- 10.1.2 Indirect Channels
- 10.2 Rabies Vaccine Distributors
- 10.3 Rabies Vaccine Customer
11 Global Rabies Vaccine Market Forecast
- 11.1 Global Rabies Vaccine Consumption Forecast (2019-2024)
- 11.2 Global Rabies Vaccine Forecast by Regions
- 11.2.1 Global Rabies Vaccine Forecast by Regions (2019-2024)
- 11.2.2 Global Rabies Vaccine Value Forecast by Regions (2019-2024)
- 11.2.3 Americas Consumption Forecast
- 11.2.4 APAC Consumption Forecast
- 11.2.5 Europe Consumption Forecast
- 11.2.6 Middle East & Africa Consumption Forecast
- 11.3 Americas Forecast by Countries
- 11.3.1 United States Market Forecast
- 11.3.2 Canada Market Forecast
- 11.3.3 Mexico Market Forecast
- 11.3.4 Brazil Market Forecast
- 11.4 APAC Forecast by Countries
- 11.4.1 China Market Forecast
- 11.4.2 Japan Market Forecast
- 11.4.3 Korea Market Forecast
- 11.4.4 Southeast Asia Market Forecast
- 11.4.5 India Market Forecast
- 11.4.6 Australia Market Forecast
- 11.5 Europe Forecast by Countries
- 11.5.1 Germany Market Forecast
- 11.5.2 France Market Forecast
- 11.5.3 UK Market Forecast
- 11.5.4 Italy Market Forecast
- 11.5.5 Russia Market Forecast
- 11.5.6 Spain Market Forecast
- 11.6 Middle East & Africa Forecast by Countries
- 11.6.1 Egypt Market Forecast
- 11.6.2 South Africa Market Forecast
- 11.6.3 Israel Market Forecast
- 11.6.4 Turkey Market Forecast
- 11.6.5 GCC Countries Market Forecast
- 11.7 Global Rabies Vaccine Forecast by Type
- 11.8 Global Rabies Vaccine Forecast by Application
12 Key Players Analysis
- 12.1 GSK (Novartis)
- 12.1.1 Company Details
- 12.1.2 Rabies Vaccine Product Offered
- 12.1.3 GSK (Novartis) Rabies Vaccine Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.1.4 Main Business Overview
- 12.1.5 GSK (Novartis) News
- 12.2 Sanofi-Pasteur
- 12.2.1 Company Details
- 12.2.2 Rabies Vaccine Product Offered
- 12.2.3 Sanofi-Pasteur Rabies Vaccine Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.2.4 Main Business Overview
- 12.2.5 Sanofi-Pasteur News
- 12.3 Chengda
- 12.3.1 Company Details
- 12.3.2 Rabies Vaccine Product Offered
- 12.3.3 Chengda Rabies Vaccine Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.3.4 Main Business Overview
- 12.3.5 Chengda News
- 12.4 Yisheng
- 12.4.1 Company Details
- 12.4.2 Rabies Vaccine Product Offered
- 12.4.3 Yisheng Rabies Vaccine Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.4.4 Main Business Overview
- 12.4.5 Yisheng News
- 12.5 Prcmise
- 12.5.1 Company Details
- 12.5.2 Rabies Vaccine Product Offered
- 12.5.3 Prcmise Rabies Vaccine Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.5.4 Main Business Overview
- 12.5.5 Prcmise News
- 12.6 VACN
- 12.6.1 Company Details
- 12.6.2 Rabies Vaccine Product Offered
- 12.6.3 VACN Rabies Vaccine Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.6.4 Main Business Overview
- 12.6.5 VACN News
- 12.7 Changsheng
- 12.7.1 Company Details
- 12.7.2 Rabies Vaccine Product Offered
- 12.7.3 Changsheng Rabies Vaccine Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.7.4 Main Business Overview
- 12.7.5 Changsheng News
- 12.8 BCHT
- 12.8.1 Company Details
- 12.8.2 Rabies Vaccine Product Offered
- 12.8.3 BCHT Rabies Vaccine Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.8.4 Main Business Overview
- 12.8.5 BCHT News
- 12.9 Hissen
- 12.9.1 Company Details
- 12.9.2 Rabies Vaccine Product Offered
- 12.9.3 Hissen Rabies Vaccine Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.9.4 Main Business Overview
- 12.9.5 Hissen News
13 Research Findings and Conclusion
Summary:
Get latest Market Research Reports on Rabies Vaccine . Industry analysis & Market Report on Rabies Vaccine is a syndicated market report, published as Global Rabies Vaccine Market Growth 2019-2024. It is complete Research Study and Industry Analysis of Rabies Vaccine market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
